Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
1 mg | 在庫あり | ¥ 36,500 | |||
5 mg | 在庫あり | ¥ 89,500 | |||
10 mg | 在庫あり | ¥ 135,500 | |||
25 mg | 在庫あり | ¥ 216,500 | |||
50 mg | 在庫あり | ¥ 294,000 | |||
100 mg | 在庫あり | ¥ 397,000 | |||
500 mg | 在庫あり | ¥ 794,000 |
説明 | Spiroglumide, a CCKB-gastrin antagonist that inhibits dose-dependent pentagastrin-induced acid hypersecretion with an ID50 of 20.1 (8.67-46.4) mg / kg, could be used to explore the physiological role of gastrin in the regulation of human gastric acid secretion. |
In vivo | Spiroglumide (25、50、75、100 mg/kg; rat) dose-dependent inhibition of pentagastrin (16 µg/kg/h) induced acid hypersecretion.[1] |
別名 | CR-2194 |
分子量 | 441.35 |
分子式 | C21H26Cl2N2O4 |
CAS No. | 137795-35-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (113.29 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Spiroglumide 137795-35-8 GPCR/G Protein cholecystokinin CR2194 CR 2194 CR-2194 Inhibitor inhibitor inhibit